SMARTTRANSVAL

Your focus: analytical method transfer

SMARTTRANSVAL is software that assesses if a method can be transferred from a “sender” lab to one or several “receiver” labs according to the tolerance interval approach.

Features

Value for you:

  • Always up-to-date and validated software, accessible from any location
  • Reduces report writing to a couple of minutes instead of days
  • Easy to use: made by statisticians for non-statistician
  • Best-in-class decision making

Enables you to:

  • Determine if a method can be transferred from a “sender” lab to one or several “receiver” labs according to the tolerance interval approach
  • Generate stand-alone transfer reports on the transfer of quantitative analytical method
  • Assess the risk of being out of specification at the new lab

Our statisticians provide support for any questions concerning the use of the software and the processing of your data.

Benefits

  • Use of Total Analytical Error (TAE) concept (i.e. combine bias and precision)
  • Up to 5 “receiver” labs analyzed in one report
  • Use of β-expectation Tolerance Interval to manage the risk in routine analysis such as suggested in USP 1210
  • Generate an e-CTD report within minutes, in full compliance with authority expectations (ICH Q2, FDA, ISO, EMA, WHO, USP 1220, USP 1210 and USP 1224)
  • Suitable for GxP use: fully validated according to the GAMP5 guidelines and 21 CFR part 11 compliant
  • Decision-making tool: one graph = one decision
  • Software as a Service (SaaS) application:
    • no installation required: no need to validate the system on site
    • no maintenance costs
    • can be accessed from any location
    • always the latest version available, free of charge

SMARTTRANSVAL – the details

For a quick overview of how SMARTTRANSVAL works, please check out our demo video >>

Contact Us

Contact Form

Complete this form to stay in contact with us.

Global Approach

PharmaLex has 60+ offices in 32 countries serving more than 1600 satisfied clients worldwide. Search your nearest office.

Scroll to Top

Suspicious Emails

We are aware of a number of suspicious emails about recruitment in circulation purporting to be from PharmaLex. Emails sent by PharmaLex will originate from @pharmalex.com. Should you receive an email and are unsure as to its validity, please report it to contact@pharmalex.com.

Many thanks for your understanding.

The PharmaLex Team